Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated?
about
Dr William Coley and tumour regression: a place in history or in the futureRisk factors for tuberculosis in foreign-born people (FBP) in Italy: a systematic review and meta-analysisTuberculosis and illicit drug use: review and update.Active and latent tuberculosis among HIV-positive injecting drug users in IndonesiaA prospective cohort study of cutaneous leishmaniasis risk and opium addiction in south eastern Iran.Mu opioid signaling protects against acute murine intestinal injury in a manner involving Stat3 signalingNOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases.Alvimopan, a selective peripherally acting mu-opioid antagonist.Methylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side effects.Clinical manifestation and risk factors of tuberculosis infection in Malaysia: case study of a community clinic.Prenatal opiate exposure attenuates LPS-induced fever in adult rats: role of interleukin-1beta.Latent and active tuberculosis: evaluation of injecting drug users.Augmentation of Cytolytic Activity in Murine Natural Killer Cells and Inhibition of Tumor Growth by the Ethanol Fraction of Oyster Extract.Effects of remifentanyl and fentanyl on LPS-induced cytokine release in human whole blood in vitro.Alleviating Mechanical Allodynia and Modulating Cellular Immunity Contribute to Electroacupuncture's Dual Effect on Bone Cancer Pain.Morphine: double-faced roles in the regulation of tumor development.Inflammasome in drug abuse.
P2860
Q24680367-2828A6A9-0F93-4E62-9AC3-4C541BAAB52AQ28537863-BD34EFB5-0388-4E22-8DF2-CCEA193105F7Q34601143-8AD57B4B-8028-41FE-989A-633D66577EBCQ35091998-EB5A475E-D1A6-463B-AEA1-CD033A7DF84CQ35106578-BBA8CE08-1F2E-4EC1-AA5A-5A10B8AC0F80Q35168195-DF602804-CB69-41DE-AE26-B8AD81F7CC86Q35708377-BFCF1B75-9DD8-4621-B596-86E5A8C44F9CQ36078760-C834FB75-0ADB-4E56-BA7B-0363D89F4D9EQ36458384-D22082E5-CA5B-4549-BE9A-96BFAA4D4E4CQ36713075-597946DD-6F61-4FA6-8621-49E7EC87B1B1Q37241460-F9C255FE-7B1A-4E47-B13B-CEE3457850CDQ37594234-8173FA45-0033-4F9F-A1DE-53E88C2AAFF2Q40421293-0D838C5B-9522-4FEE-AA0E-CC4DE083BA8EQ46521662-DE4C68BD-0937-463A-8F84-421D82CCB0B3Q47651674-AC448DCD-E0F1-47BE-A545-D90F58622C09Q47711705-056AA646-9FDC-4448-8976-A55AF788D157Q47852970-6102886B-F1A2-4EF6-A0C5-642FE0180251
P2860
Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated?
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated?
@ast
Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated?
@en
type
label
Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated?
@ast
Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated?
@en
prefLabel
Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated?
@ast
Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated?
@en
P2093
P1476
Opioid-induced immunosuppression: is it centrally mediated or peripherally mediated?
@en
P2093
Chun Su Yuan
Jonathan Moss
P304
P356
10.1016/S0006-2952(03)00085-6
P407
P577
2003-06-01T00:00:00Z